Table 2 Clinical characteristics and immune-related indicators in MM patients.

From: Peroxiredoxins as novel indicators in multiple myeloma associated with ferroptosis and immune infiltration

Characteristics

PRDX2 expression

P value

Low (n = 14)

High (n = 14)

Gender (n, %)

Female

6(42.90)

3(21.40)

0.420

Male

8(57.10)

11(78.60)

 

Isotype (n, %)

Light chain

1(7.10)

5(35.70)

0.101

IgA

8(57.10)

4(28.60)

 

IgG

5(35.70)

3(21.40)

 

Other

0(0.00)

2(14.30)

 

PET-CT/MRI (n, %)

 < 3

5(35.7)

3(21.4)

0.678

 ≥ 3

9(64.3)

11(78.6)

 

Age (years)

60.21 ± 7.27

60.79 ± 9.16

0.856

β2-microglobin (ng/ml)

2588.00

5159.50

 < 0.001

Creatinine (umol/l)

62.50

76.15

0.094

Calcium serum (mmol/l)

2.24 ± 0.10

2.23 ± 0.13

0.712

CD4 + T (%)

43.73 ± 6.66

31.05 ± 9.56

 < 0.001

CD8 + T (%)

33.08 ± 9.69

46.50 ± 14.25

0.007

CD4 + T/CD8 + T

1.25

0.69

0.001

IL-6 (pg/ml)

2.60

5.61

0.035

IL-8 (pg/ml)

2.60

12.20

 < 0.001

IL-12p70 (pg/ml)

1.57

0.66

0.014

  1. PET-CT Positron emission tomography-computed tomography; MRI Magnetic resonance imaging.
Back to article page